205241-12-9

Basic information

• Product Name: (S)-2-(4-Methoxy-phenyl)-butyryl chloride
• Synonyms: (S)-2-(4-Methoxy-phenyl)-butyryl chloride
• CAS NO: 205241-12-9
• Molecular Weight: 212.676
• Mol File: 205241-12-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-2-(4-Methoxy-phenyl)-butyryl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-(4-Methoxy-phenyl)-butyryl chloride(205241-12-9)
• EPA Substance Registry System: (S)-2-(4-Methoxy-phenyl)-butyryl chloride(205241-12-9)

Safety Data

• Hazardous Substances Data: 205241-12-9(Hazardous Substances Data)

Upstream product

• 205240-95-5 (S)-2-(4-Methoxy-phenyl)-butyric acid methyl ester 
• 131343-07-2 methyl 2-allyl-2-(p-methoxy)phenylacetate 
• 4646-94-0 2-(4-methoxyphenyl)-n-butanoic acid 
• 39066-09-6 2-(4-methoxy)-phenyl-butyronitrile 
• 13491-20-8 (S)-2-(4-methoxyphenyl)-butanoic acid 

Relevant articles and documents

(S)-N-HYDROXY-2-(2-(4-METHOXYPHENYL)BUTANAMIDO)THIAZOLE-5-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

The invention relates to the compound (S)-n-hydroxy-2-(2-(4-methoxyphenyl) butanamido)thiazole-5-carboxamide, which is a novel histone deacetylase inhibitor. The invention further relates to the use of the compound for the inhibition of histone deacetylating activities of HDAC isoforms and treatment of histone deacetylase (HDAC)-associated diseases. The invention also relates to the pharmaceutical compositions and the making of the pharmaceutical compositions comprising the compound.